Elanco to Showcase Innovations at Morgan Stanley Global Healthcare Conference 2026

Elanco's Significant Participation at the Morgan Stanley Global Healthcare Conference

Elanco Animal Health Incorporated, known for its dedication to improving animal health, is set to make a significant appearance at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. This participation underscores Elanco’s commitment to animal health innovation, as well as their ongoing efforts to enhance the lives of farm animals and pets alike.

During the conference, key executives from Elanco will be present, including Jeff Simmons, the president and CEO, Bob VanHimbergen, the executive vice president and CFO, and Bobby Modi, the executive vice president focusing on U.S. Pet Health and Global Digital Transformation. This distinguished group will engage in a fireside chat, which is scheduled to take place at 2:35 PM ET on the day of the event.

A live audio webcast of this chat will be accessible in the “Events and Presentations” section on Elanco’s investor relations website, ensuring that interested parties can follow along regardless of their physical location. Following the live event, a replay will also be available for a limited time, allowing those unable to attend the session to catch up on the insights shared.

The Morgan Stanley Global Healthcare Conference serves as a notable platform that highlights the most promising trends and innovations in the healthcare sector, including animal health. Elanco, with a proud heritage of more than 70 years, continually seeks to break boundaries in the industry. The company’s vision focuses on Food and Companionship Enriching Life, which encapsulates their mission to provide significant value to farmers, pet owners, veterinarians, and the broader community.

Elanco Animal Health has carved a niche for itself as a global leader in animal health. The company is recognized for its innovative approaches to developing products and services that play a crucial role in the prevention and treatment of diseases affecting both farm and companion animals. Commitment to societal welfare through sustainable practices remains a fundamental pillar of their operations.

In light of their stature and expertise, Elanco is keen on leveraging the insights from industry specialists to refine their strategies and enhance their offerings. As they prepare for this major conference, stakeholders are keenly interested in the outcomes of their discussions, which may unveil Elanco's future direction and innovations.

Overall, Elanco's representation at the Morgan Stanley Healthcare Conference not only signifies its leadership in animal health but also its commitment to advancing the welfare of animals and contributing to the health sector in meaningful ways. The event is expected to showcase Elanco's plans for future innovations and reinforce its role in the evolving landscape of animal health.

For more information about Elanco and their participation in the conference, interested parties are encouraged to visit Elanco's official website.